Detail akcie Ekso Bions Hldgs Rg online

Business Summary: Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Ekso Bionics Holdings Inc revenues decreased 1% to $8.7M. Net loss decreased 32% to $5.8M. Revenues reflect EksoHealth segment decrease of 4% to $8.3M, United States segment decrease of 26% to $4.9M, Romania segment decrease of 62% to $181K. Lower net loss reflects General And Administration Expense decrease of 29% to $3.8M (expense), Sales and marketing - Balancing value decrease of 16% to $3.6M (expense).